Form 8-K Medicus Pharma Ltd. For: Dec 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Medicus Pharma establishes $15.3 million at-the-market equity program
December 30, 2025 9:29 AM ESTMedicus Pharma Ltd. (NASDAQ: MDCX) entered into an equity distribution agreement on December 29, 2025, with Maxim Group LLC and Yorkville Securities LLC to establish an at-the-market equity program worth up to $15,349,674.
Under the agreement, the company may sell common shares from... More
